A Personalized Medicine Approach: Psychosocial and Genetic Risk Assessments Predictors of Bariatric Surgery Outcomes After 3 Years
Authors:
- Panayotis K. ThanosPanayotis K. Thanos
- Shtakshe ChatrathSCShtakshe Chatrath
- Colin HannaCHColin Hanna
- Fiona ComstockFCFiona Comstock
- John ButschJBJohn Butsch
- Kenneth BlumKenneth Blum
- Albert PinhasovAPAlbert Pinhasov
- Lucy MastrandreaLMLucy Mastrandrea
- Teresa QuattrinTQTeresa Quattrin
- Lesley GeorgerLGLesley Georger
- Alan PosnerAPAlan Posner
Open Access
- 10 April 2026
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 14 (4) , 870
Abstract
Background: This study aimed to further explore the application of genetic risk assessments in 24 metabolic bariatric surgery (MBS) patients to predict weight loss outcomes three years after the procedure. Methods: Participants were assessed using the Genetic Addiction Risk Severity (GARS) test, which evaluates neurogenic polymorphisms linked to addiction and reward deficiency. Genetic and psychosocial data collected prior to surgery were analyzed in relation to post-operative weight loss measures, including weight change, body mass index (BMI), percentage of total weight loss (%TWL), and percentage of expected weight loss (%EWL). The analysis examined associations between specific genetic risk alleles, weight-related outcomes at three to four years post-surgery, and psychosocial trait scores. Results: Spearman’s correlations revealed that the DRD2 risk allele is negatively correlated with 3-year BMI (rs = −0.481, p < 0.05, 95% CI: –0.746 to –0.083). One-way ANOVA indicated that there is a significant difference in 3-year BMI (p = 0.018) between 0 and 1 DRD2 risk allele copy. There is also a significant difference in ∆weight (p = 0.022), ∆BMI (p = 0.014), and %EWL (p = 0.032) among the different SNP expression values of the MAOA risk allele. In addition, Spearman’s correlation revealed that FCQ scores are negatively correlated with ∆BMI (rs = −0.470, p < 0.05, 95% CI: −0.767, −0.005), %TWL (rs = −0.561, p < 0.05, 95% CI: −0.814, −0.129), and %EWL (rs = −0.533, p < 0.05, 95% CI: −0.800, −0.090) at 3 years post-surgery and positively correlated with 3-year weight (rs = 0.576, p < 0.05, 95% CI: 0.151, 0.821) and 3-year BMI (rs = 0.552, p < 0.05, 95% CI: 0.117, 0.810). Lastly, GARS scores are positively correlated with 3-year ∆weight (rs = 0.422, p < 0.05, 95% CI: 0.010, 0.712).Keywords
Funding Information
- Blue Sky Foundation (BL1152833)
This publication has 65 references indexed in Scilit:
- Validation of the Difficulties in Emotion Regulation Scale‐Short Form in a sample of Italian adolescentsJournal of Clinical Psychology, 2024
- Cumulative Genetic Score of DRD2 Polymorphisms Is Associated with Impulsivity and Masked Semantic PrimingJournal of Molecular Neuroscience, 2022
- High Genetic Addiction Risk Score (GARS) in Chronically Prescribed Severe Chronic Opioid Probands Attending Multi-pain Clinics: an Open Clinical Pilot TrialMolecular Neurobiology, 2021
- Effect of Laparoscopic Sleeve Gastrectomy vs Roux-en-Y Gastric Bypass on Weight Loss and Quality of Life at 7 Years in Patients With Morbid ObesityJAMA Surgery, 2021
- Validation of the Yale Food Addiction Scale 2.0 in Patients Seeking Bariatric SurgeryObesity Surgery, 2021
- Epigenetic signature of MAOA and MAOB genes in mental disordersJournal of Neural Transmission, 2018
- Eating Expectancies in Relation to Eating Disorder RecoveryCognitive Therapy and Research, 2013
- Association of dopamine D2 receptor and leptin receptor genes with clinically severe obesityObesity, 2012
- Further association study on dopamine D2 receptor variant S311C in schizophrenia and affective disordersAmerican Journal of Medical Genetics, 1996
- Allelic Association of the D2 Dopamine Receptor Gene With Receptor-Binding Characteristics in Alcoholism or Gene ismArchives of General Psychiatry, 1991